Comparison of Thyroglobulin Concentrations Measured by Two Immunoradiometric Assay

1. Cooper DS, Doherty GM, Haugen BR, et al. (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.Search in Google Scholar

2. Pacini F, Schlumberger M, Dralle H, et al. (2006). European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol, 154:787–803.Search in Google Scholar

3. Feldt-Rasmussen U, Profilis C, Colinet E, et al. (1996). Human thyroglobulin reference material (CRM 457). 1st part: assessment of homogeneity, stability and immunoreactivity. Annales de Biologie Clinique Paris, 54:337–342.Search in Google Scholar

4. Stanojevic M, Savin S, Cvejic D, et al. (2009). Correlation of thyroglobulin concentrations measured by radioimmunoassay and immunometric assay and the influence of thyroglobulin antibody. J Immunoassay Immunochem, 30:197-207.Search in Google Scholar

5. Stanojevic M, Savin S, Cvejic D, et al. (2009). Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients. J Clin Lab Anal, 23:341-346.Search in Google Scholar

6. Görges R, Maniecki M, Jentzen W, et al. (2005). Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol,153:49-55.Search in Google Scholar

7. Spencer CA, LoPresti JS. (2008). Technology insight: Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Endocrinol Metab,4:223-233.Search in Google Scholar

8. Spencer CA, Bergoglio LM, Kazarosyan M, et al. (2005). Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab, 90:5566-5575.Search in Google Scholar

9. Cheng X, Yu S, Jin C, Han S, et al. (2017). Comparison of three different assays for measuring thyroglobulin and thyroglobulin antibodies in patients with chronic lymphocytic thyroiditis. Clinical Biochemistry, 50(18):1183-1187.Search in Google Scholar

10. Giovanella L, Clark P, Chiovato L, et al. (2014). Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper. Eur J Endocrinol, 171:R33–R46Search in Google Scholar

11. Netzel BC, Grebe SKG, Carranza Leon BG, et al. (2015). Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes. The Journal of Clinical Endocrinology and Metabolism, 100(8):E1074-E1083. doi:10.1210/jc.2015-1967.10.1210/jc.2015-1967452499326079778Search in Google Scholar

12. Schlumberger M, Hitzel A, Toubert ME, et al. (2007). Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients. J Clin Endocrinol Metab, 92:2487–2495.Search in Google Scholar

13. Okosieme OE, Evans C, Moss L, et al. (2005). Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem, 51(4):729-734.Search in Google Scholar

14. Estienne B, McIntosh RS, Ruf J, et al. (1998). Comparative mapping of cloned human and murine antithyroglobulin antibodies: recognition of human antibodies of an immunodominant region. Thyroid, 8: 643–648.Search in Google Scholar

15. Lee JI, Kim JY, Choi JY, et al. (2010). Differences in serum thyroglobulin measurements by 3 commercial immunoradiometric assay kits and laboratory standardization using Certified Reference Material 457 (CRM-457) Head Neck, 32:1161–1166.10.1002/hed.2130820029980Search in Google Scholar

16. Spencer C, Fatemi S. (2013). Thyroglobulin antibody (TgAb) methods -Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer. Best Pract Res Clin Endocrinol Metab, 27:701–712.Search in Google Scholar

17. Mazzaferri EL, Robbins RJ, Spencer CA, et al. (2003). A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab, 88(4):1433-1441.Search in Google Scholar

18. Vrndic O, Savin S, Mijatovic Lj, et al. (2011). Concentration of Thyroglobulin and Thyroglobulin-Specific Autoantibodies in Patients With Differentiated Thyroid Cancer After Treatment With Radioactive Iodine 131, Lab Medicine, 42(1):27–3110.1309/LMNC7I58JNJMCPKWSearch in Google Scholar

19. Cho YY, Chun S, Lee S-Y, et al. (2016). Performance Evaluation of the Serum Thyroglobulin Assays With Immunochemiluminometric Assay and Immunoradiometric Assay for Differentiated Thyroid Cancer. Ann Lab Med, 36(5):413-419. doi:10.3343/alm.2016.36.5.413.10.3343/alm.2016.36.5.413494048327374705Search in Google Scholar

20. Spencer C, LoPresti J, Fatemi S. (2014). How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies. Curr Opin Endocrinol Diabetes Obes,21(5):394-404. doi: 10.1097/MED.0000000000000092.10.1097/MED.0000000000000092415479225122493Search in Google Scholar